Philippe Villain-Guillot
CEO Nosopharm
Philippe Villain-Guillot has been Nosopharm’s CEO since co-founding the company in 2009. In this first entrepreneurial venture, he established a robust IP portfolio, dealt a co-development agreement with a major biotech company, and has raised €14 million in private equity and non-dilutive funding. Philippe holds a PhD in medicinal chemistry.